创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

武琦梅, 葛建. 神经药理学研究进展[J]. 药学进展, 2019, 43(2): 83-92.
引用本文: 武琦梅, 葛建. 神经药理学研究进展[J]. 药学进展, 2019, 43(2): 83-92.
WU Qimei, GE Jian. Progress in Neuropharmacology[J]. Progress in Pharmaceutical Sciences, 2019, 43(2): 83-92.
Citation: WU Qimei, GE Jian. Progress in Neuropharmacology[J]. Progress in Pharmaceutical Sciences, 2019, 43(2): 83-92.

神经药理学研究进展

Progress in Neuropharmacology

  • 摘要: 近年来,随着神经科学、结构生物学、分子影像学等学科的迅速发展,我国在神经药理领域取得了丰富的研究成果。通过对我国学者2016—2017年在相关学术期刊中发表的论文进行检索和整理,从阿尔茨海默病、帕金森病、脑卒中、抑郁等方向对我国学者在神经药理领域所取得的研究进展进行综述,旨在为后续相关药物研究提供参考。

     

    Abstract: In recent years, with the rapid development of neuroscience, structural biology, molecular imaging and other disciplines, many scientific discoveries and breakthroughs have been made by Chinese scientists in the field of neuropharmacology. By retrieving the papers published by Chinese scholars from 2016 to 2017, this article reviewed their achievements in neuropharmacology from the perspectives of Alzheimer's disease, Parkinson's disease, stroke, and depression, providing reference for future discoveries of neurological drugs.

     

/

返回文章
返回